The Gene Vaccine Revolution

Genetic vaccination is destined to change the way in which we prevent and treat a variety of human diseases. Numerous studies have demonstrated that this novel technology can have significant advantages over traditional methods of vaccination.

Our group belongs to the European pioneers of DNA and RNA vaccine research. Together with national and international collaboration partners from scientific institutes and companies, we have developed vaccines against malaria, borreliosis, tumor antigens and type I allergy. During the past six years, the latter became our pet subject. At present we focus on genetic vaccination strategies for highly effective and safety-optimized vaccines for protective and therapeutic approaches against allergic diseases. 

Ao. Prof. Dr Thalhamer  is the coordinator  of the international
 "PhD Program ICA" of the University of Salzburg and the FWF

Ao. Prof. Dr Thalhamer is speaker of the priority programme "BioScience and Health"  of the University of Salzburg

and a member of the "Christian Doppler Laboratory
for Allergy Diagnosis and Therapy"